• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

Professional Introduction to N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide (CAS No. 349553-74-8)

N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide, identified by its CAS number 349553-74-8, is a specialized chemical compound that has garnered significant attention in the field of pharmaceutical research and development. This compound belongs to a class of molecules that exhibit promising biological activities, making it a subject of extensive study in medicinal chemistry. The unique structural features of this compound, particularly the presence of both an amine and a nitro group, contribute to its potential as a lead molecule in the synthesis of novel therapeutic agents.

The chemical structure of N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide consists of a benzene ring substituted with a nitro group at the 2-position and a sulfonamide moiety at the 1-position. The 4-aminobutyl side chain extends from the sulfonamide group, introducing a polar and basic character to the molecule. This combination of functional groups makes the compound highly versatile, allowing for interactions with various biological targets. The nitro group, in particular, is known for its ability to participate in redox reactions, which can be exploited in the development of prodrugs or bioactivatable compounds.

In recent years, there has been growing interest in exploring the pharmacological properties of nitroaromatic compounds. The nitro group can be reduced to an amine under physiological conditions, leading to significant changes in the biological activity of the molecule. This redox-sensitive property has been leveraged in the design of targeted therapies, where the conversion of the nitro group to an amine can activate a drug within a specific cellular environment. N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide is no exception and has been investigated for its potential role in modulating inflammatory pathways and cancer cell proliferation.

One of the most compelling aspects of N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide is its ability to interact with enzymes and receptors involved in critical biological processes. The amine group at the 4-position provides a hydrogen bond acceptor capability, which is essential for binding to biological targets such as kinases and transcription factors. Additionally, the sulfonamide group enhances water solubility, facilitating better absorption and distribution within biological systems. These properties make it an attractive candidate for further development into a drug candidate.

Recent studies have demonstrated that derivatives of nitroaromatic sulfonamides exhibit significant anti-inflammatory and anticancer activities. For instance, researchers have shown that certain analogs of N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide can inhibit the activity of cyclooxygenase (COX) enzymes, which are key players in inflammation. Moreover, preclinical studies have indicated that these compounds can induce apoptosis in cancer cells by modulating mitochondrial function and reactive oxygen species (ROS) generation. These findings underscore the therapeutic potential of this class of molecules.

The synthesis of N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide involves multi-step organic reactions that require precise control over reaction conditions. The introduction of the nitro group onto the benzene ring is typically achieved through electrophilic aromatic substitution, while the sulfonamide formation is accomplished via nucleophilic substitution or condensation reactions. The 4-aminobutyl side chain is then introduced through subsequent functionalization steps. Advanced synthetic techniques such as palladium-catalyzed cross-coupling reactions have been employed to enhance yield and purity, ensuring that the final product meets pharmaceutical standards.

In conclusion, N-(4-aminobutyl)-2-nitrobenzene-1-sulfonamide (CAS No. 349553-74-8) represents a promising candidate for further exploration in drug discovery. Its unique structural features and demonstrated biological activities make it a valuable asset in medicinal chemistry research. As our understanding of molecular interactions continues to evolve, compounds like this are likely to play a crucial role in developing innovative therapies for various diseases.

• 832730-54-8(Benzenesulfonamide, N,N'-1,5-pentanediylbis[2-nitro-)
• 89840-65-3(Benzenesulfonamide,N-(2-methylpropyl)-2-nitro-)
• 89840-63-1(2-nitro-N-propylbenzene-1-sulfonamide)
• 437718-20-2(Benzenesulfonamide,N-(5-aminopentyl)-2-nitro-, hydrochloride (1:1))
• 240423-09-0(Benzenesulfonamide,N-(3-aminopropyl)-2-nitro-)
• 89840-64-2(N-Butyl-2-Nitrobenzenesulfonamide)
• 211512-13-9(N-(4-Aminobutyl)-2-nitrobenzenesulfonamide)
• 716316-26-6(Benzenesulfonamide, N-cyclobutyl-2-nitro-)
• 89840-68-6(Benzenesulfonamide, 2-nitro-N-octyl-)
• 89840-67-5(Benzenesulfonamide, N-hexyl-2-nitro-)